Financials

  • Market Capitalization 10.8 B
  • Employee 915
  • Founded 2011
  • CEO Paul A. Friedman
  • Website www.madrigalpharma.com
  • Headquarter Delaware, United States
  • FIGI BBG000QS6NV8
  • Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-45.32
市销率
13.63

Related tickers

#姓名价格24小时 %7天 %一个月 %一年 %市值最近7天
842
IBRX
ImmunityBio, Inc. - Common Stock
10.15 USD-3.43%-1.65%+28.64%+326.47%10.76 B USD
850
PCVX
Vaxcyte, Inc. - Common Stock
69.06 USD-3.25%-5.10%+15.02%+63.26%10.28 B USD
856
BMRN
BioMarin Pharmaceutical Inc. - Common Stock
55.89 USD+1.99%-3.32%-15.95%+6.76%10.82 B USD
891
KNSA
Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares
79.60 USD-0.23%+4.27%+2.20%+100.78%10.13 B USD

新闻